- Home
- NNN vs ASND Comparison
NNN vs ASND Comparison
Compare NNN & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNN
- ASND
- Stock Information
- Founded
- NNN 1984
- ASND 2006
- Country
- NNN United States
- ASND Denmark
- Employees
- NNN N/A
- ASND N/A
- Industry
- NNN Real Estate Investment Trusts
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- NNN Real Estate
- ASND Health Care
- Exchange
- NNN Nasdaq
- ASND Nasdaq
- Market Cap
- NNN 8.6B
- ASND 7.3B
- IPO Year
- NNN N/A
- ASND 2015
- Fundamental
- Price
- NNN $42.18
- ASND $126.51
- Analyst Decision
- NNN Hold
- ASND Strong Buy
- Analyst Count
- NNN 6
- ASND 13
- Target Price
- NNN $46.17
- ASND $191.77
- AVG Volume (30 Days)
- NNN 1.4M
- ASND 422.4K
- Earning Date
- NNN 10-31-2024
- ASND 11-14-2024
- Dividend Yield
- NNN 5.50%
- ASND N/A
- EPS Growth
- NNN 1.10
- ASND N/A
- EPS
- NNN 2.16
- ASND N/A
- Revenue
- NNN $867,015,000.00
- ASND $365,187,374.00
- Revenue This Year
- NNN N/A
- ASND $10.30
- Revenue Next Year
- NNN $4.31
- ASND $90.02
- P/E Ratio
- NNN $19.54
- ASND N/A
- Revenue Growth
- NNN 6.99
- ASND 115.54
- 52 Week Low
- NNN $38.49
- ASND $90.13
- 52 Week High
- NNN $49.57
- ASND $161.00
- Technical
- Relative Strength Index (RSI)
- NNN 30.60
- ASND 46.41
- Support Level
- NNN $41.72
- ASND $124.11
- Resistance Level
- NNN $43.33
- ASND $129.86
- Average True Range (ATR)
- NNN 0.89
- ASND 5.50
- MACD
- NNN -0.14
- ASND 0.28
- Stochastic Oscillator
- NNN 19.85
- ASND 56.59
About NNN NNN REIT Inc.
NNN REIT Inc is a real estate investment trust that invests in and develops properties throughout the United States. The company generates revenue from leasing properties to tenants, including convenience stores, automotive services, fitness centers, theatres, restaurants, and banks. Rents from convenience stores and restaurants contribute the majority proportion of total revenue, followed by automotive services, entertainment venues, and others. maximum of the company's properties are located in the South and Southeast of the United States.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.